Moreover, GIST48 and GIST430 cells harbor KIT mutations in exon 11/17 and exon 11/13, respectively, and are responsible for over 50% of IM-resistant cases of GIST. This evidence concerns the gene KIT and gastrointestinal stromal tumor.